RG

REGENXBIO

- NASDAQ:RGNX
Last Updated 2024-05-02

Indeed Snapshot

Track REGENXBIO reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:rgnx https://www.indeed.com/cmp/regenxbio-inc.-1 Aug 29th, 2022 12:00AM Open REGENXBIO REGENXBIO’s NAV® Technology Platform has ushered in a new era of gene therapy innovation. We are leveraging our proprietary NAV Technology Platform and collaborating with world-class clinical advisors to advance the development of life-changing gene therapy treatments for metabolic, neurodegenerative and retinal diseases. Beyond these core areas of focus, we are licensing our NAV Technology Platform to enable global strategic partners to advance gene therapy programs for other serious diseases with unmet needs, such as hemophilia, Pompe disease and spinal muscular atrophy. RRv1_1M_5M Rockville Ken Mills 3.80 5.00 5.00 4.00 4.60 3.00 3.60 3.40 Aug 29th, 2022 12:30PM Aug 29th, 2022 12:30PM REGENXBIO Health Care Pharmaceuticals & Biotechnology
nasdaq:rgnx https://www.indeed.com/cmp/regenxbio-inc.-1 Aug 28th, 2022 12:00AM Open REGENXBIO REGENXBIO’s NAV® Technology Platform has ushered in a new era of gene therapy innovation. We are leveraging our proprietary NAV Technology Platform and collaborating with world-class clinical advisors to advance the development of life-changing gene therapy treatments for metabolic, neurodegenerative and retinal diseases. Beyond these core areas of focus, we are licensing our NAV Technology Platform to enable global strategic partners to advance gene therapy programs for other serious diseases with unmet needs, such as hemophilia, Pompe disease and spinal muscular atrophy. RRv1_1M_5M Rockville Ken Mills 3.80 5.00 5.00 4.00 4.60 3.00 3.60 3.40 Aug 28th, 2022 05:30AM Aug 28th, 2022 05:30AM REGENXBIO Health Care Pharmaceuticals & Biotechnology
nasdaq:rgnx https://www.indeed.com/cmp/regenxbio-inc.-1 Aug 27th, 2022 12:00AM Open REGENXBIO REGENXBIO’s NAV® Technology Platform has ushered in a new era of gene therapy innovation. We are leveraging our proprietary NAV Technology Platform and collaborating with world-class clinical advisors to advance the development of life-changing gene therapy treatments for metabolic, neurodegenerative and retinal diseases. Beyond these core areas of focus, we are licensing our NAV Technology Platform to enable global strategic partners to advance gene therapy programs for other serious diseases with unmet needs, such as hemophilia, Pompe disease and spinal muscular atrophy. RRv1_1M_5M Rockville Ken Mills 3.80 5.00 5.00 4.00 4.60 3.00 3.60 3.40 Aug 27th, 2022 04:49AM Aug 27th, 2022 04:49AM REGENXBIO Health Care Pharmaceuticals & Biotechnology
nasdaq:rgnx https://www.indeed.com/cmp/regenxbio-inc.-1 Aug 25th, 2022 12:00AM Open REGENXBIO REGENXBIO’s NAV® Technology Platform has ushered in a new era of gene therapy innovation. We are leveraging our proprietary NAV Technology Platform and collaborating with world-class clinical advisors to advance the development of life-changing gene therapy treatments for metabolic, neurodegenerative and retinal diseases. Beyond these core areas of focus, we are licensing our NAV Technology Platform to enable global strategic partners to advance gene therapy programs for other serious diseases with unmet needs, such as hemophilia, Pompe disease and spinal muscular atrophy. RRv1_1M_5M Rockville Ken Mills 3.80 5.00 5.00 4.00 4.60 3.00 3.60 3.40 Aug 25th, 2022 09:28AM Aug 25th, 2022 09:28AM REGENXBIO Health Care Pharmaceuticals & Biotechnology
nasdaq:rgnx https://www.indeed.com/cmp/regenxbio-inc.-1 Aug 23rd, 2022 12:00AM Open REGENXBIO REGENXBIO’s NAV® Technology Platform has ushered in a new era of gene therapy innovation. We are leveraging our proprietary NAV Technology Platform and collaborating with world-class clinical advisors to advance the development of life-changing gene therapy treatments for metabolic, neurodegenerative and retinal diseases. Beyond these core areas of focus, we are licensing our NAV Technology Platform to enable global strategic partners to advance gene therapy programs for other serious diseases with unmet needs, such as hemophilia, Pompe disease and spinal muscular atrophy. RRv1_1M_5M Rockville Ken Mills 3.80 5.00 5.00 4.00 4.60 3.00 3.60 3.40 Aug 23rd, 2022 11:21AM Aug 23rd, 2022 11:21AM REGENXBIO Health Care Pharmaceuticals & Biotechnology
nasdaq:rgnx https://www.indeed.com/cmp/regenxbio-inc.-1 Aug 21st, 2022 12:00AM Open REGENXBIO REGENXBIO’s NAV® Technology Platform has ushered in a new era of gene therapy innovation. We are leveraging our proprietary NAV Technology Platform and collaborating with world-class clinical advisors to advance the development of life-changing gene therapy treatments for metabolic, neurodegenerative and retinal diseases. Beyond these core areas of focus, we are licensing our NAV Technology Platform to enable global strategic partners to advance gene therapy programs for other serious diseases with unmet needs, such as hemophilia, Pompe disease and spinal muscular atrophy. RRv1_1M_5M Rockville Ken Mills 3.80 5.00 5.00 4.00 4.60 3.00 3.60 3.40 Aug 21st, 2022 01:06PM Aug 21st, 2022 01:06PM REGENXBIO Health Care Pharmaceuticals & Biotechnology
nasdaq:rgnx https://www.indeed.com/cmp/regenxbio-inc.-1 Aug 20th, 2022 12:00AM Open REGENXBIO REGENXBIO’s NAV® Technology Platform has ushered in a new era of gene therapy innovation. We are leveraging our proprietary NAV Technology Platform and collaborating with world-class clinical advisors to advance the development of life-changing gene therapy treatments for metabolic, neurodegenerative and retinal diseases. Beyond these core areas of focus, we are licensing our NAV Technology Platform to enable global strategic partners to advance gene therapy programs for other serious diseases with unmet needs, such as hemophilia, Pompe disease and spinal muscular atrophy. RRv1_1M_5M Rockville Ken Mills 3.80 5.00 5.00 4.00 4.60 3.00 3.60 3.40 Aug 20th, 2022 02:43PM Aug 20th, 2022 02:43PM REGENXBIO Health Care Pharmaceuticals & Biotechnology
nasdaq:rgnx https://www.indeed.com/cmp/regenxbio-inc.-1 Aug 19th, 2022 12:00AM Open REGENXBIO REGENXBIO’s NAV® Technology Platform has ushered in a new era of gene therapy innovation. We are leveraging our proprietary NAV Technology Platform and collaborating with world-class clinical advisors to advance the development of life-changing gene therapy treatments for metabolic, neurodegenerative and retinal diseases. Beyond these core areas of focus, we are licensing our NAV Technology Platform to enable global strategic partners to advance gene therapy programs for other serious diseases with unmet needs, such as hemophilia, Pompe disease and spinal muscular atrophy. RRv1_1M_5M Rockville Ken Mills 3.80 5.00 5.00 4.00 4.60 3.00 3.60 3.40 Aug 19th, 2022 01:05PM Aug 19th, 2022 01:05PM REGENXBIO Health Care Pharmaceuticals & Biotechnology
nasdaq:rgnx https://www.indeed.com/cmp/regenxbio-inc.-1 Aug 18th, 2022 12:00AM Open REGENXBIO REGENXBIO’s NAV® Technology Platform has ushered in a new era of gene therapy innovation. We are leveraging our proprietary NAV Technology Platform and collaborating with world-class clinical advisors to advance the development of life-changing gene therapy treatments for metabolic, neurodegenerative and retinal diseases. Beyond these core areas of focus, we are licensing our NAV Technology Platform to enable global strategic partners to advance gene therapy programs for other serious diseases with unmet needs, such as hemophilia, Pompe disease and spinal muscular atrophy. RRv1_1M_5M Rockville Ken Mills 3.80 5.00 5.00 4.00 4.60 3.00 3.60 3.40 Aug 18th, 2022 04:49AM Aug 18th, 2022 04:49AM REGENXBIO Health Care Pharmaceuticals & Biotechnology
nasdaq:rgnx https://www.indeed.com/cmp/regenxbio-inc.-1 Aug 17th, 2022 12:00AM Open REGENXBIO REGENXBIO’s NAV® Technology Platform has ushered in a new era of gene therapy innovation. We are leveraging our proprietary NAV Technology Platform and collaborating with world-class clinical advisors to advance the development of life-changing gene therapy treatments for metabolic, neurodegenerative and retinal diseases. Beyond these core areas of focus, we are licensing our NAV Technology Platform to enable global strategic partners to advance gene therapy programs for other serious diseases with unmet needs, such as hemophilia, Pompe disease and spinal muscular atrophy. RRv1_1M_5M Rockville Ken Mills 3.80 5.00 5.00 4.00 4.60 3.00 3.60 3.40 Aug 17th, 2022 10:28AM Aug 17th, 2022 10:28AM REGENXBIO Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.